| Market Cap | 799M 694M 647M 594M 1.12B 75.99B 1.14B 7.63B 2.98B 37.99B 3B 2.93B 126B | P/E 2023 |
2,007x | P/E 2024 | -3.42x |
|---|---|---|---|---|---|
| Enterprise Value | 964M 837M 781M 717M 1.36B 91.72B 1.37B 9.2B 3.6B 45.85B 3.62B 3.54B 152B | EV / Sales 2023 |
8.58x | EV / Sales 2024 | 4.64x |
| Free-Float |
98.58% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -2.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2025-09-14 | |
Richard McAvoy
DFI | Director of Finance/CFO | - | 2026-05-31 |
David Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 2025-10-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | +7.69% | - | - | 799M | |
| +0.19% | +9.42% | +33.09% | -0.75% | 75.96B | |
| +2.24% | -8.97% | +22.24% | +185.79% | 49.03B | |
| +3.72% | -4.71% | -8.40% | +20.60% | 47.88B | |
| +1.42% | +2.02% | -51.10% | -50.16% | 43.39B | |
| +3.29% | +1.38% | +57.68% | -22.49% | 30.8B | |
| +1.83% | -7.18% | +54.54% | +89.53% | 24.45B | |
| +3.36% | +2.12% | +106.19% | -47.32% | 22.75B | |
| +4.15% | +0.67% | -8.56% | +210.84% | 19.24B | |
| +0.55% | -7.19% | +59.71% | +117.00% | 15.87B | |
| Average | +1.79% | -0.84% | +29.49% | +55.89% | 36.6B | |
| Weighted average by Cap. | +2.04% | +0.79% | +22.14% | +43.10% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 149M 130M 121M 111M 210M 14.2B 212M 1.42B 557M 7.1B 561M 548M 23.52B | 140M 121M 113M 104M 197M 13.31B 199M 1.34B 522M 6.65B 525M 514M 22.04B |
| Net income | 560K 486K 453K 416K 788K 53.27M 796K 5.35M 2.09M 26.63M 2.1M 2.06M 88.23M | -141M -122M -114M -105M -198M -13.39B -200M -1.34B -525M -6.69B -529M -517M -22.18B |
| Net Debt | 151M 131M 122M 112M 213M 14.38B 215M 1.44B 564M 7.19B 568M 555M 23.83B | 165M 144M 134M 123M 233M 15.73B 235M 1.58B 617M 7.86B 621M 607M 26.05B |
Employees
-
Sector
Pharmaceuticals
